Open AccessSTAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas
Author(s) -
Nadège Dubois,
Sharon Berendsen,
Katherine Tan,
Laurent Schoysmans,
Wim G.M. Spliet,
Tatjana Seute,
Vincent Bours,
Pierre A. Robe
Publication year - 2022
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.2022.5414
Subject(s) - gene knockdown , biology , temozolomide , cancer research , clonogenic assay , cell cycle , tissue microarray , oncogene , cell growth , transcription factor , cell , cell culture , oncology , glioma , medicine , immunohistochemistry , immunology , gene , biochemistry , genetics